Details for New Drug Application (NDA): 018605
✉ Email this page to a colleague
NDA 018605 describes AZULFIDINE, which is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in two NDAs. It is available from five suppliers. Additional details are available on the AZULFIDINE profile page.
The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
Summary for 018605
| Tradename: | AZULFIDINE |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | sulfasalazine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018605
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 250MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
